
Gene therapy entered the clinical arena more than one decade ago. Hundreds of clinical trials were initiated worldwide to investigate many different approaches to oncological problems. Positive results became available only recently, showing that gene therapy is actually capable of curing human neoplasms. This editorial scrutinizes the whole field of gene therapy for cancer, describing advantages and disadvantages of the various approaches, and trying to forecast the main future developments.

